Licensing
MaxCyte is capitalizing on the strength of its IP estate by forming major alliances with leading pharmaceutical and biotech companies. In addition, MaxCyte is offering licenses to its technology to Academic and Translational Medicine Centers.
MaxCyte provides its partners with the most advanced non-viral, gene transfer system for the clinical setting. Additionally, the company's expertise in engineering, regulatory affairs, and molecular/cell biology add great value to its partnerships. MaxCyte's business development objectives are:
- Partner with leading cell-based therapeutics companies
- Partner with therapeutic companies seeking non-viral gene delivery
- Partner with companies seeking to develop scalable solutions for viral vector manufacturing
We invite you to explore possibilities regarding a strategic collaboration, feasibility study, or similar relationships. Please contact:
|
